Use of peptides for altering bone resorption

Details Use of peptides for altering bone resorption Use of peptides for altering bone resorption

1995-04-12

1998-08-11

Russel, Jeffrey E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 12, 514 13, 514 14, 514 15, 514 16, 514 17, 530317, 530324, 530325, 530326, 530327, 530328, 530329, A61K 3808, A61K 3812, C07K 706, C07K 754

Patent

active

057927456

ABSTRACT:
The present invention provides Arg-Gly-Asp peptides that can alter the binding of osteoclasts to a matrix such as bone or can selectively alter integrin receptor binding. The invention also provides methods of using the Arg-Gly-Asp peptides to alter .alpha..sub.v .beta..sub.3 integrin receptor-mediated binding of a cell such as an osteoclast, endothelial cell or smooth muscle cell to a matrix. The invention further provides methods for ameliorating the severity of a pathology characterized, in part, by an undesirable level of bone resorption, angiogenesis or restenosis in a subject.

REFERENCES:
patent: 4517686 (1985-05-01), Ruoslahti et al.
patent: 4578079 (1986-03-01), Ruoslahti et al.
patent: 4589881 (1986-05-01), Pierschbacher et al.
patent: 4614517 (1986-09-01), Ruoslahti et al.
patent: 4654314 (1987-03-01), Takagi et al.
patent: 4661111 (1987-04-01), Ruoslahti et al.
patent: 4792525 (1988-12-01), Ruoslahti et al.
patent: 5041380 (1991-08-01), Ruoslahti et al.
patent: 5192746 (1993-03-01), Lobl et al.
patent: 5227469 (1993-07-01), Lazarus et al.
Reinholt, Finn P. et al., "Osteopontin--a Possible Anchor of Osteoclasts to Bone." Proc. Natl. Acad. Sci. USA. 87:4473-4475 (1990).
Denhardt, David T. and Guo, Xiaojia, "Osteopontin: A Protein with Diverse Functions." FASEB J. 7:1475-1482 (1993).
Nesbitt, Stephen et al., "Biochemical Characterization of Human Osteoclast Integrins." J. Biol. Chem. 268:16737-16745 (1993).
Hughes, D.E. et al., "Integrin Expression in Human Bone." J. Bone & Mineral Res. 8:527-533 (1993).
Chuntharapai Anan et al., "Blocking Monoclonal Antibodies to .alpha..sub.v .beta..sub.3 Integrin: A Unique Epitope of .alpha..sub.v .beta..sub.3 Integrin is Present on Human Osteoclasts." Experimental Cell Res. 205:345-352 (1993).
Helfrich, Miep H. et al., "Rat Osteoclasts Adhere to a Wide Range of RGD (Arg-Gly-Asp) Peptide-Containing Proteins, Including the Bone Sialoproteins and Fibronectin, via a .beta..sub.3 Integrin." J. Bone and Mineral Res. 7:335-343 (1992).
Yamakawa, Kensuke et al., "An Arg-Gly-Asp Peptide Stimulates Ca.sup.2+ Efflux From Osteoclast Precursors Through a Novel Mechanism." American Physiological Society. 651-657 (1994).
Horton, M.A. et al., "Arg-Gly-Asp (RGD) Peptides and the Anti-Vitronectin Receptor Antibody 23c6 Inhibit Dentine Resorption and Cell Spreading by Osteoclasts." Experimental Cell Res. 195:368-375 (1991).
Horton, Michael A. et al., "Modulation of Vitronectin Receptor-Mediated Osteoclast Adhesion by Arg-Gly-Asp Peptide Analogs: A Structure-Function Analysis." J. Bone and Mineral Res. 8:239-247 (1993).
Sato, M. et al., "Echistatin is a Potent Inhibitor of Bone Resorption in Culture." J. Cell Biol. 111:1713-1723 (1990).
Roudebush, Roger E. et al., "Effect of Weight Manipulation on Bone Loss Due to Ovariectomy and the Protective Effects of Estrogen in the Rat." Calcfied. Tissue Int. 53:61-64 (1993).
Gronowicz, Gloria A. and Derome, Mary E. "Synthetic Peptide Containing Arg-Gly-Asp Inhibits Bone Formation and Resorption in a Mineralizing Organ Culture System of Fetal Rat Parietal Bones." J. Bone and Mineral Res. 9:193-201 (1994).
Aumailley et al., "Arg-Gly-Asp Constrained within Cyclic Pentapeptides Strong and Selective Inhibitors of Cell Adhesion to Vitronectin and Laminin Fragment P1," FEBS Letters 291(1):50-54 (1991).
Fauchere et al., "Modulation of the Activity and Assessment of the Receptor Selectivity in a Series of New RGD-containing Peptides," Int'l J. Peptide & Protein Res. 42(5):440-444 (1993).
PCT Search Report (dated 9 Nov. 1995), International application No. PCT/US95/04741.
J. Bone Mineral Research, vol. 9, No. 2 (Feb. 1994)--Title Page and Date Stamp Page.
J. Biol. Chem., vol. 268, No.13, Issued 15 May 1993, Ross et al, "Interaction Between the Bone Matrix . . . ", pp. 9901-9907.
J. Vasc. Surg., vol. 19, No. 1, Issued Jan. 1994, Choi et al, "Inhibition of Neointimal . . . ", pp. 125-134.
Endocrin., vol. 132, No. 3, Issued Mar. 1993, Fisher et al, "Inhibition of Osteoclastic Bone . . . ", pp. 1411-1413.
J. Biol. Chem., vol. 263, Issued 25 Dec. 1988, Gan et al, "Echistatin", pp. 19827-19832.
J. Biol. Chem., vol. 266, No. 30, Issued 25 Oct. 1991, Miyauchi et al, "Recognition of Osteopontin . . . ", pp. 20369-20374.

Affiliated with

Also associated with

Rating

Use of peptides for altering bone resorption does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of peptides for altering bone resorption, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of peptides for altering bone resorption will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-389006